KPTI (STOCKS)
Karyopharm Therapeutics Inc.
$8.100000
+0.100000 (+1.25%)
Prev close: $8.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard A. Paulson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $186.21M
- Employees
- 279
- P/E (TTM)
- -0.50
- P/B (TTM)
- -0.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $146.07M |
| Benefits Costs and Expenses | $342.06M |
| Costs And Expenses | $342.06M |
| Nonoperating Income/Loss | -$105.29M |
| Operating Expenses | $236.77M |
| Selling, General, and Administrative Expenses | $105.21M |
| Research and Development | $125.62M |
| Other Operating Expenses | $5.95M |
| Operating Income/Loss | -$90.71M |
| Income/Loss From Continuing Operations After Tax | -$196.04M |
| Income/Loss From Continuing Operations Before Tax | -$196.00M |
| Income Tax Expense/Benefit | $43.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$196.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$196.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$196.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$17.93 |
| Diluted Earnings Per Share | -$17.93 |
| Basic Average Shares | 10,935 |
| Diluted Average Shares | 10,935 |
| Assets | $108.42M |
| Current Assets | $103.15M |
| Cash | $63.70M |
| Accounts Receivable | $26.18M |
| Inventory | $4.04M |
| Other Current Assets | $9.23M |
| Noncurrent Assets | $5.27M |
| Fixed Assets | $104.00K |
| Other Non-current Assets | $5.17M |
| Liabilities | $401.34M |
| Current Liabilities | $92.06M |
| Accounts Payable | $4.00M |
| Wages | $4.38M |
| Other Current Liabilities | $83.68M |
| Noncurrent Liabilities | $309.28M |
| Equity | -$292.93M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$292.93M |
| Liabilities And Equity | $108.42M |
| Net Cash Flow From Operating Activities | -$75.37M |
| Net Cash Flow From Operating Activities, Continuing | -$75.37M |
| Net Cash Flow From Investing Activities | $43.38M |
| Net Cash Flow From Investing Activities, Continuing | $43.38M |
| Net Cash Flow From Financing Activities | $30.05M |
| Net Cash Flow From Financing Activities, Continuing | $30.05M |
| Exchange Gains/Losses | $20.00K |
| Net Cash Flow | -$1.92M |
| Net Cash Flow, Continuing | -$1.94M |
| Comprehensive Income/Loss | -$195.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$195.61M |
| Other Comprehensive Income/Loss | $427.00K |